Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 12,535 | 13,133 | 14,493 | 16,832 | 17,540 |
| Cost of Goods | 5,120 | 5,878 | 6,389 | 7,181 | 6,447 |
| Gross Profit | 7,415 | 7,255 | 8,104 | 9,651 | 11,093 |
| Operating Expenses | 10,451 | 11,008 | 14,381 | 11,547 | 11,973 |
| Operating Income | -2,916 | -2,875 | -5,888 | -1,715 | -433 |
| Interest Expense | 2,005 | 2,089 | 2,037 | 2,038 | 1,869 |
| Other Income | 12 | -544 | -25 | 276 | 251 |
| Pre-tax Income | -4,909 | -5,508 | -7,950 | -3,477 | -2,051 |
| Income Tax | 2 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -4,911 | -5,508 | -7,950 | -3,488 | -2,051 |
| Net Income | $-4,911 | $-5,508 | $-7,950 | $-3,488 | $-2,051 |
| EPS Basic Total Ops | -0.10 | -0.11 | -0.16 | -0.07 | -0.04 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.16 | -0.07 | -0.04 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -0.16 | -0.07 | -0.04 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.16 | -0.07 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.11 | -0.16 | -0.07 | -0.04 |
| EBITDA(a) | $-1,105 | $-1,317 | $-4,521 | $-199 | $824 |